0001562180-21-007298.txt : 20211126
0001562180-21-007298.hdr.sgml : 20211126
20211126162646
ACCESSION NUMBER: 0001562180-21-007298
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211123
FILED AS OF DATE: 20211126
DATE AS OF CHANGE: 20211126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clark George C.
CENTRAL INDEX KEY: 0001878290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 211452031
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-11-23
false
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001878290
Clark George C.
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN
CT
06510
false
true
false
false
VP, Chief Accounting Officer
Common Shares
2021-11-23
4
M
false
1915.00
32.42
A
7473.00
D
Common Shares
2021-11-26
4
M
false
5000.00
0.00
A
12473.00
D
Common Shares
2021-11-26
4
F
false
2318.00
115.55
D
10155.00
D
Employee Stock Option (right to buy)
32.42
2021-11-23
4
M
false
1915.00
0.00
D
2028-11-20
Common Shares
1915.00
4795.00
D
Restricted Share Unit Award
2021-11-26
4
M
false
5000.00
0.00
D
Common Shares
5000.00
15000.00
D
No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
The shares underlying this option vest in four equal installments on November 20, 2019, 2020, 2021 and 2022, subject to the reporting person's continued service with the issuer at each vesting date.
Each restricted share unit represents the contingent right to receive one common share of the issuer.
The reporting person was granted 20,000 restricted share units on May 7, 2021, vesting in four equal installments on May 7, 2021, 2022, 2023 and 2024 subject to the reporting person's continued service with the issuer at each vesting date.
Not applicable.
/s/ George C. Clark
2021-11-26